Hims & Hers Health Inc. (HIMS)
Hims & Hers Health Statistics
Share Statistics
Hims & Hers Health has 213.79M shares outstanding. The number of shares has increased by 3.58% in one year.
Shares Outstanding | 213.79M |
Shares Change (YoY) | 3.58% |
Shares Change (QoQ) | 1.75% |
Owned by Institutions (%) | 75.8% |
Shares Floating | 181.95M |
Failed to Deliver (FTD) Shares | 2.98K |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 57.77M, so 26% of the outstanding shares have been sold short.
Short Interest | 57.77M |
Short % of Shares Out | 26% |
Short % of Float | 29.55% |
Short Ratio (days to cover) | 2.71 |
Valuation Ratios
The PE ratio is 41.43 and the forward PE ratio is 31.68. Hims & Hers Health's PEG ratio is -0.07.
PE Ratio | 41.43 |
Forward PE | 31.68 |
PS Ratio | 3.54 |
Forward PS | 1.2 |
PB Ratio | 10.95 |
P/FCF Ratio | 24.93 |
PEG Ratio | -0.07 |
Enterprise Valuation
Hims & Hers Health has an Enterprise Value (EV) of 5.01B.
EV / Sales | 3.39 |
EV / EBITDA | 80.97 |
EV / EBIT | 19.96 |
EV / FCF | 23.93 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.02.
Current Ratio | 1.79 |
Quick Ratio | 1.5 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.18 |
Debt / FCF | 0.05 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 26.44% and Return on Invested Capital is 22.29%.
Return on Equity | 26.44% |
Return on Assets | 17.81% |
Return on Invested Capital | 22.29% |
Revenue Per Employee | $901.96K |
Profits Per Employee | $76.99K |
Employee Count | 1,637 |
Asset Turnover | 2.09 |
Inventory Turnover | 4.71 |
Taxes
Income Tax | -54.33M |
Effective Tax Rate | -75.76% |
Stock Price Statistics
The stock price has increased by 120.75% in the last 52 weeks. The beta is 1.66, so Hims & Hers Health's price volatility has been higher than the market average.
Beta | 1.66 |
52-Week Price Change | 120.75% |
50-Day Moving Average | 37.83 |
200-Day Moving Average | 26.52 |
Relative Strength Index (RSI) | 42.26 |
Average Volume (20 Days) | 24.94M |
Income Statement
In the last 12 months, Hims & Hers Health had revenue of 1.48B and earned 126.04M in profits. Earnings per share was 0.58.
Revenue | 1.48B |
Gross Profit | 1.17B |
Operating Income | 61.9M |
Net Income | 126.04M |
EBITDA | 61.9M |
EBIT | 61.9M |
Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 220.58M in cash and 11.35M in debt, giving a net cash position of 209.24M.
Cash & Cash Equivalents | 220.58M |
Total Debt | 11.35M |
Net Cash | 209.24M |
Retained Earnings | -242.14M |
Total Assets | 707.54M |
Working Capital | 174.46M |
Cash Flow
In the last 12 months, operating cash flow was 251.08M and capital expenditures -41.66M, giving a free cash flow of 209.43M.
Operating Cash Flow | 251.08M |
Capital Expenditures | -41.66M |
Free Cash Flow | 209.43M |
FCF Per Share | 0.97 |
Margins
Gross margin is 79.45%, with operating and profit margins of 4.19% and 8.54%.
Gross Margin | 79.45% |
Operating Margin | 4.19% |
Pretax Margin | 4.86% |
Profit Margin | 8.54% |
EBITDA Margin | 4.19% |
EBIT Margin | 4.19% |
FCF Margin | 14.18% |
Dividends & Yields
HIMS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.41% |
FCF Yield | 4.01% |
Analyst Forecast
The average price target for HIMS is $34, which is 24.8% higher than the current price. The consensus rating is "Hold".
Price Target | $34 |
Price Target Difference | 24.8% |
Analyst Consensus | Hold |
Analyst Count | 12 |
Scores
Altman Z-Score | 17.63 |
Piotroski F-Score | 5 |